101 results
S-8
EX-23.1
nzie1x0q xo8sdbon
15 Aug 23
Registration of securities for employees
4:14pm
S-8
EX-23.2
ljbqtv9 l1bx8
15 Aug 23
Registration of securities for employees
4:14pm
6-K
EX-99.1
t4ek7ja6ph noh0icn2s
15 Aug 23
MediWound Reports Second Quarter 2023 Financial Results and Provides
4:10pm
6-K
EX-99.1
vnemq
10 Jul 23
MediWound Announces Positive Results in Its U.S. Phase I/II Study of MW005
7:35am
6-K
ogdyw npwy
31 May 23
Current report (foreign)
4:05pm
6-K
EX-99.2
l7xz2bw83
20 Apr 23
Current report (foreign)
4:06pm
6-K
EX-99.1
8r3b1yygcl4u6w
20 Apr 23
Current report (foreign)
4:06pm
424B3
52v3fhakv h8wrrdlxz
6 Apr 23
Prospectus supplement
4:06pm
POS AM
EX-23.2
03sbf7ianz9kvc2mi
31 Mar 23
Prospectus update (post-effective amendment)
7:00am
POS AM
EX-23.1
838dtf5yvyhadoigx43
31 Mar 23
Prospectus update (post-effective amendment)
7:00am
POS AM
uvibh 0f2
31 Mar 23
Prospectus update (post-effective amendment)
7:00am
6-K
EX-99.1
xobffq 6zp37
19 Dec 22
MediWound Announces Positive Results in U.S. Phase I/II Study of MW005
7:28am
424B3
lla63nh0ktg495gi7jqr
25 Nov 22
Prospectus supplement
5:10pm
F-1
EX-23.2
ibuqit
10 Nov 22
Registration statement (foreign)
4:13pm
F-1
oru6w0 le21
10 Nov 22
Registration statement (foreign)
4:13pm